Pfizer

Will Olivier Brandicourt Have a Free Hand to Make Changes at Sanofi?
WSJ Pharmalot
Fri, 02/20/15 - 10:18 am
Sanofi
Pharma CEOs
Olivier Brandicourt
diabetes
Pfizer
Has Pfizer Inc. Finally Solved Its Immuno-oncology Problem?
Motley Fool
Wed, 02/18/15 - 10:56 am
Pfizer
immuno-oncology
AstraZeneca
Bristol-Myers Squibb
Merck
Roche
To Pfizer's Chantix, a new JAMA study sounds like 14M potential patients
Fierce Pharma Marketing
Wed, 02/18/15 - 08:22 am
Chantix
Pfizer
JAMA
smoking cessation
How Pfizer Is Using Big Data To Power Patient Care
Forbes
Tue, 02/17/15 - 12:57 pm
Pfizer
Big Data
FirstWord Lists – The best selling drugs in 2014
First Word Pharma
Mon, 02/16/15 - 04:50 pm
Humira
Sovaldi
Remicade
Enbrel
Lantus
Rituxan
Advair
Avastin
Herceptin
Januvia
Merck
AbbVie
Gilead Sciences
JNJ
Amgen
Pfizer
Sanofi
Roche
GSK
If Pfizer's Right, Hospira Biosimilar Gold Rush Begins This Week
Forbes
Mon, 02/16/15 - 11:55 am
Pfizer
Hospira
M&A
biosimilars
Inflectra
Europe
autoimmune disease
Deal-Hungry Pfizer Won't Stop With Hospira; Who Could Be Next?
Motley Fool
Mon, 02/16/15 - 10:19 am
Pfizer
Hospira
M&A
Teva Pharmaceutical
AbbVie
Bristol-Myers Squibb
Abbott Labs
Mylan
GSK
Pfizer Announces FDA Acceptance for Review of a New Drug Application for ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride)
Yahoo/BusinessWire
Sat, 02/14/15 - 10:22 am
Pfizer
ALO-02
opiods
pain management
Indian pharma giants scuffle to snap up injectables maker Claris
BioPharma Dive
Fri, 02/13/15 - 10:30 am
India
injectables
M&A
Claris Lifesciences
Lupin
Cipla
Zydus Cadilla
Pfizer
Why Pfizer Might Not Split Anytime Soon
Seeking Alpha
Thu, 02/12/15 - 09:09 am
Pfizer
Hospira CEO Ball stands to reap $80M on Pfizer buyout
Fierce Pharma
Thu, 02/12/15 - 09:08 am
Hospira
Pfizer
M&A
executive pay
F. Michael Ball
Hospira–Pfizer merger: Benefits from growing biosimilars market
Yahoo/Market Realist
Thu, 02/12/15 - 09:07 am
Hospira
Pfizer
M&A
biosimilars
Will Pfizer Inc. Break Up in 2015?
Motley Fool
Wed, 02/11/15 - 07:56 am
Pfizer
Big Pharma Faces Some Big Patent Losses, but Pipelines are Improving
WSJ Pharmalot
Tue, 02/10/15 - 08:41 am
patents
Big Pharma
Abilify
Amgen
AstraZeneca
Biogen Idec
Bristol-Myers Squibb
Crestor
Eli Lilly
Gilead Sciences
GSK
Harvoni
Hospira
Merck
Novo Nordisk
Pfizer
Sovaldi
Tecfidera
Pfizer Inc. GEP Unit To Become Largest Biosimilar And Generic Drugs Developer
Bidness Etc.
Mon, 02/9/15 - 10:34 am
Pfizer
biosimilars
generics
Hospira
M&A
Pfizer Inc. Is Not Done With Acquisition Deals Yet
Bidness Etc.
Mon, 02/9/15 - 10:02 am
Pfizer
M&A
Hospira
Actavis
GSK
Bristol-Myers Squibb
Forget Pfizer! This Big Pharmaceutical Stock is Better
Motley Fool
Sun, 02/8/15 - 10:03 am
Pfizer
Novo Nordisk
Hospira acquisition might fetch Pfizer 3 plants in India
Business Standard, India
Sat, 02/7/15 - 10:58 am
Hospira
Pfizer
M&A
India
The Pfizer-Hospira Deal: Do Pharma and Device Companies Need Each Other?
Mass Device
Fri, 02/6/15 - 05:48 pm
Pfizer
Hospira
devices
M&A
Pfizer (PFE) Stock Dips Today Amid Reports of More Acquisitions
TheStreet.com
Fri, 02/6/15 - 10:33 am
Pfizer
M&A
Actavis
Hospira

Pages